Annexon Analyst Ratings
Wells Fargo Maintains Overweight on Annexon, Lowers Price Target to $10
Analysts Offer Insights on Healthcare Companies: Alcon (ALC), Annexon Biosciences (ANNX) and Ascendis Pharma (ASND)
Annexon Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Annexon, Maintains $30 Price Target
Buy Rating on Annexon Biosciences Backed by Efficacious ANX007 Data and Meticulous Phase 3 Trial Design
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Annexon Biosciences (ANNX) and Cytokinetics (CYTK)
Analysts Conflicted on These Healthcare Names: Guardant Health (GH), Argenx Se (ARGX) and Annexon Biosciences (ANNX)
Annexon Analyst Ratings
Needham Reiterates Buy on Annexon, Maintains $16 Price Target
Cantor Fitzgerald Corp.: Annexon (ANNX.US) shareholding rating confirmed.
Annexon Analyst Ratings
Annexon Analyst Ratings
Needham: Reiterates the Annexon (ANNX.US) rating and adjusted from buy to buy rating, target price is $16.00.
Buy Rating on Annexon Biosciences: Promising Pipeline and Strategic Growth Potential
Annexon Analyst Ratings
Annexon Analyst Ratings
JP Morgan Maintains Overweight on Annexon, Raises Price Target to $13
Analysts Are Bullish on Top Healthcare Stocks: Annexon Biosciences (ANNX), Insmed (INSM)
Annexon Analyst Ratings
No Data